CJC-1295 vs Melanotan II
A comprehensive, data-driven comparison of CJC-1295 (Modified GRF 1-29) and Melanotan II (MT-2). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | CJC-1295 Modified GRF 1-29, DAC:GRF | Melanotan II MT-2, Melanotan 2 |
|---|---|---|
| FDA Status | Category 2 (pending reclassification) | Not submitted |
| Category | Growth Hormone | Sexual Health |
| Primary Use | Growth hormone optimization and anti-aging | Tanning and sexual dysfunction (research) |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $35 - $70/mo | $30 - $60/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 1-2mg twice weekly (with DAC) | 0.25-1mg 2-3x per week |
| Frequency | Twice weekly | As needed |
| Mechanism | Growth hormone releasing hormone (GHRH) analog that stimulates pituitary gland to produce more growth hormone | Melanocortin receptor agonist that stimulates melanogenesis for tanning and has effects on sexual arousal |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Emerging | Low |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1Melanotan II is generally more affordable ($30 - $60/mo) compared to CJC-1295 ($35 - $70/mo).
- 2CJC-1295 is dosed twice weekly, while Melanotan II is as needed.
- 3Melanotan II has low-quality evidence, while CJC-1295 has emerging-quality evidence.
- 4They belong to different categories: CJC-1295 (Growth Hormone) vs Melanotan II (Sexual Health).
Which Is Better For...
Melanotan II
More budget-friendly option with lower monthly costs
Melanotan II
More convenient dosing schedule (as needed)
CJC-1295
Fewer commonly reported side effects
Melanotan II
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| CJC-1295 | $35 - $70/mo | Category 2 (pending reclassification) | Various research labs |
| Melanotan II | $30 - $60/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
CJC-1295 works via Growth hormone releasing hormone (GHRH) analog that stimulates pituitary gland to produce. Melanotan II works via Melanocortin receptor agonist that stimulates melanogenesis for tanning and has effects on. They differ in FDA approval status, efficacy data, and cost.
CJC-1295 typically costs $35 - $70/mo, while Melanotan II costs $30 - $60/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
CJC-1295 is not FDA-approved (Category 2 (pending reclassification)). Melanotan II is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of CJC-1295 include Injection site reactions, Water retention, Numbness or tingling. Common side effects of Melanotan II include Nausea, Flushing, Spontaneous erections. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
CJC-1295 is a synthetic analog of growth hormone releasing hormone (GHRH) that stimulates the pituitary gland to release growth hormone. It exists in two forms: with DAC (Drug Affinity Complex) for ex...
View Full CJC-1295 GuideMelanotan II is a synthetic analog of alpha-melanocyte stimulating hormone that binds to melanocortin receptors. Originally developed for skin tanning protection against UV damage, it was found to hav...
View Full Melanotan II GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between CJC-1295 and Melanotan II should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.